First Report of the Durability of the Antibody Response in Maintenance Hemodialysis Patients and Kidney Transplant Recipients Vaccinated with Two Doses of the ChAdOx1 nCoV-19 Vaccine: A Prospective, Comparative, Multicenter, Observational Study
The immunogenicity of COVID-19 vaccines in maintenance hemodialysis (MHD) and kidney transplant recipients (KTR) are suboptimal. However, there are no data on the durability of the humoral response with the ChAdOx1 nCoV-19 vaccine in these groups. This was a multicenter, prospective cohort study of...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| سلاسل: | Saudi Journal of Kidney Diseases and Transplantation |
| الوصول للمادة أونلاين: | https://journals.lww.com/10.4103/sjkdt.sjkdt_187_22 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
